Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aladorian - RyCarma Therapeutics

Next Previous
Drug Profile

Aladorian - RyCarma Therapeutics

Alternative Names: ARM036; ARM036Na; S36; S36Na; S44121; S44121-1; S44121-2

Latest Information Update: 02 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ARMGO Pharma
  • Developer RyCarma Therapeutics; Servier
  • Class 2 ring heterocyclic compounds; Acids; Antiarrhythmics; Heart failure therapies; Small molecules; Thiazepines
  • Mechanism of Action Ryanodine receptor calcium release channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Chronic heart failure; Polymorphic catecholergic ventricular tachycardia

Most Recent Events

  • 07 Jan 2025 ARMGO Pharma is now called RyCarma Therapeutics
  • 17 Aug 2017 Clinical development is ongoing in Heart failure, arrhythmia and Polymorphic catecholergic ventricular tachycardia in Europe (ARMGO Pharma pipeline, August 2017)
  • 10 Dec 2014 Clinical development is ongoing in Heart failure, arrhythmia and Polymorphic catecholergic ventricular tachycardia in Europe

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top